Corporate ActionJul 22, 2026, 05:31 PM
China Pharma Holdings Prices $5M Registered Direct Offering
AI Summary
China Pharma Holdings, Inc. announced the pricing of a registered direct offering of 2.5 million shares of its common stock at $2.00 per share. This offering is expected to generate gross proceeds of $5 million for the company, before deducting fees and expenses. The net proceeds will be used for working capital and general corporate purposes. The closing is anticipated around July 23, 2026, with FT Global Capital, Inc. acting as the exclusive placement agent.
Key Highlights
- Priced registered direct offering of 2.5 million common shares.
- Purchase price set at $2.00 per share.
- Expected gross proceeds of $5 million.
- Net proceeds for working capital and general corporate purposes.
- FT Global Capital, Inc. is the exclusive placement agent.
- Placement agent to receive 7.0% cash fee.
- Closing expected on or about July 23, 2026.
Price Impact
More from CPHI